Home › Graves Disease › North Carolina
Graves Disease clinical trials in North Carolina
8 studies for Graves Disease are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Asheville Clinical Research, Asheville
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07722546Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-038, Asheville
- Site-011, Greenville
- Site-063, Morehead City
- and 4 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Oct 1, 2026 · NCT07661056NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1106, Morehead City
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 30, 2026 · NCT07305818Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Clinical Research Site, Raleigh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1010, Chapel Hill
- Site Number - 1026, Hickory
- Site Number - 1001, Morehead City
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT07018323A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1051, Asheville
- Site Number - 1060, Wilmington
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
- Site-108, Greenville
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
- Appalachian State University, Boone
Recruiting
Ages 18 to 65 · All sexes · Updated Jul 30, 2026 · NCT07413874From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.